Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.82 | ||
| Change(%) | ![]() | +0.01 | |
| Volume | 261532 | ||
| 1:16 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Concludes Tender Offer for a Portion of Its Debt
Enzon Announces Clinical Data From PEG-SN38 and rhMBL Studies at ASCO -- Company will host reception --
Enzon to Present at BMO Capital Markets Focus on Healthcare Conference
Enzon Reports Solid Second Quarter 2008 Results
-- Product revenues increase 17% --

Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon Commences Phase II Trial of PEG-SN38
-- Conference Call With Principal Investigators to be Held Tomorrow--
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting
